Skip to content
value.today

Branch Therapeutics, Inc.

🇺🇸 Houston, Texas, USAPharmaceuticalsFounded 2024
Total raised
$4 M
1 round on record
Latest round
$4 M
Apr 2025
First round on record
Apr 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Branch Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$4 MNo. 1$2 to $10 million

Branch Therapeutics, Inc.: Raise no. 1, Apr 2025

Investors in this round

1 investor had bought by the notice of May 23, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Curtis Thorne · Executive Officer, Director · CEO and Director
  • Christopher Hulme · Director
  • Sourav Banerjee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Curtis Thorne, Ceo. Newest notice filed May 23, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Branch Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Branch Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Branch Therapeutics, Inc.
NameRoleNamed in
Curtis ThorneCEO and DirectorMay 2025
Christopher HulmeDirectorMay 2025
Curtis ThorneCEO and DirectorMay 2025
Sourav BanerjeeDirectorMay 2025